EMA recommended the first oral GLP-1 drug for weight loss | Wegovy https://ymaho.com/ema-recommended-the-first-oral-glp-1-drug-for-weight-loss-wegovy
EMA issued a positive opinion on the first oral GLP-1 Wegovy for weight loss. Analysis of efficacy, price, side effects and market forecast. Read details.
Sonidegib and pazufloxacin recommended in the List of Vital and Essential Drugs https://ymaho.com/sonidegib-and-pazufloxacin-recommended-in-the-list-of-vital-and-essential-drugs
The Russian Ministry of Health recommended including sonidegib for skin cancer and the antibiotic pazufloxacin in the List of Vital and Essential Drugs. Learn about new available medications.
EMA approved the first oral GLP-1 drug Wegovy for weight control https://ymaho.com/ema-approved-the-first-oral-glp-1-drug-wegovy-for-weight-control
EMA recommended the first GLP-1 tablet for weight loss — Wegovy (semaglutide) 25 mg. Efficacy up to 16.6% weight loss. Market analysis, winners and losers. Learn more.
EMA approval of first-line treatment for aggressive colon cancer https://ymaho.com/ema-approval-of-first-line-treatment-for-aggressive-colon-cancer
EMA recommended encorafenib + cetuximab + FOLFOX for first-line BRAF V600E-mutant mCRC. 47% reduction in risk of progression. Read analysis and BREAKWATER study data.
EMA approved SMA gene therapy Itvisma and a drug for MS https://ymaho.com/ema-approved-sma-gene-therapy-itvisma-and-a-drug-for-ms
European regulator recommended Itvisma for adults with SMA and Cenrifki for secondary progressive sclerosis. Learn how a one-time injection and a pill fill gaps in neurodegeneration treatment.
Oral Ebola inhibitor: post-exposure prophylaxis https://ymaho.com/oral-ebola-inhibitor-post-exposure-prophylaxis
We analyze what EMA actually recommended regarding the first oral drug against Ebola. Key facts, logistics, and forecasts. Read.
MTS Dividends 2026: 35 rubles per share, yield 15% https://ymaho.com/mts-dividends-2026-35-rubles-per-share-yield-15
MTS reported a 46% increase in net profit and recommended dividends of 35 rubles per share. Who is the real beneficiary? Price forecast before and after the ex-dividend date. Read the analysis.
PSB recommends buying financial sector stocks and Transneft https://ymaho.com/psb-recommends-buying-financial-sector-stocks-and-transneft
Analysis of PSB's recommendation on Sberbank, VTB, and Transneft stocks. Find out why dividend stocks could be a trap for investors. Read the forecast for 30 and 90 days.
Mbappe Recommends Pochettino for Real Madrid Manager Role https://lrivo.com/mbappe-recommends-pochettino-for-real-madrid-manager-role
Kylian Mbappe reportedly advises Real Madrid to hire Mauricio Pochettino over Jurgen Klopp as their next manager. Get the latest on the Madrid managerial search.